Electromed Stock Fundamentals
| ELMD Stock | USD 14.13 0.27 1.87% |
Electromed fundamentals help investors to digest information that contributes to Electromed's financial success or failures. It also enables traders to predict the movement of Electromed Stock. The fundamental analysis module provides a way to measure Electromed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Electromed stock.
At present, Electromed's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 44.1 M, whereas Interest Expense is forecasted to decline to about 85.2 K. Electromed | Select Account or Indicator |
Electromed Company Operating Margin Analysis
Electromed's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Electromed Operating Margin | 0.17 % |
Most of Electromed's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Electromed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Electromed Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Electromed has an Operating Margin of 0.1653%. This is 100.47% lower than that of the Health Care Equipment & Supplies sector and 100.42% lower than that of the Health Care industry. The operating margin for all United States stocks is 103.0% lower than that of the firm.
Electromed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Electromed's current stock value. Our valuation model uses many indicators to compare Electromed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Electromed competition to find correlations between indicators driving Electromed's intrinsic value. More Info.Electromed is rated # 2 in return on equity category among related companies. It is rated # 2 in return on asset category among related companies reporting about 0.69 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Electromed is roughly 1.44 . At present, Electromed's Return On Equity is projected to increase slightly based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value Electromed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Electromed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Electromed's earnings, one of the primary drivers of an investment's value.Electromed Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromed's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics of similar companies.Electromed is currently under evaluation in operating margin category among related companies.
Electromed Current Valuation Drivers
We derive many important indicators used in calculating different scores of Electromed from analyzing Electromed's financial statements. These drivers represent accounts that assess Electromed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Electromed's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 129.3M | 96.7M | 81.7M | 90.6M | 81.6M | 85.7M | |
| Enterprise Value | 118.9M | 84.9M | 73.6M | 83.4M | 75.1M | 78.8M |
Electromed Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0721 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 115.76 M | ||||
| Shares Outstanding | 8.61 M | ||||
| Shares Owned By Insiders | 26.69 % | ||||
| Shares Owned By Institutions | 32.78 % | ||||
| Number Of Shares Shorted | 42.93 K | ||||
| Price To Earning | 23.66 X | ||||
| Price To Book | 3.10 X | ||||
| Price To Sales | 2.42 X | ||||
| Revenue | 48.07 M | ||||
| Gross Profit | 36.52 M | ||||
| EBITDA | 4.62 M | ||||
| Net Income | 3.17 M | ||||
| Cash And Equivalents | 8.15 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 161 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.83 X | ||||
| Book Value Per Share | 4.69 X | ||||
| Cash Flow From Operations | 1.31 M | ||||
| Short Ratio | 1.06 X | ||||
| Earnings Per Share | 0.45 X | ||||
| Target Price | 26.0 | ||||
| Number Of Employees | 170 | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 123.92 M | ||||
| Total Asset | 45.81 M | ||||
| Retained Earnings | 18.79 M | ||||
| Working Capital | 29.73 M | ||||
| Current Asset | 15.82 M | ||||
| Current Liabilities | 3.07 M | ||||
| Net Asset | 45.81 M |
About Electromed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -92 K | -87.4 K | |
| Total Revenue | 55.3 M | 58 M | |
| Cost Of Revenue | 13.3 M | 13.9 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.79 | 0.74 | |
| Research And Ddevelopement To Revenue | 0.02 | 0.03 | |
| Capex To Revenue | (0.03) | (0.03) | |
| Revenue Per Share | 5.11 | 5.37 | |
| Ebit Per Revenue | 0.07 | 0.06 |
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
| 0.89 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Electromed Stock
| 0.89 | IVP | Inspire Veterinary | PairCorr |
| 0.79 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.77 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.62 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
| 0.54 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Electromed Piotroski F Score and Electromed Altman Z Score analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.